![Young-Sun Sohn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Young-Sun Sohn
Corporate Officer/Principal at Catholic University of Korea
Young-Sun Sohn active positions
Companies | Position | Start | End |
---|---|---|---|
Catholic University of Korea | Corporate Officer/Principal | 14/09/2011 | - |
Career history of Young-Sun Sohn
Former positions of Young-Sun Sohn
Companies | Position | Start | End |
---|---|---|---|
Abxign, Inc.
![]() Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | President | 14/09/2011 | 24/07/2013 |
CJ CORPORATION | Chief Tech/Sci/R&D Officer | - | - |
DAEWOONG PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | - | - |
Statistics
International
South Korea | 5 |
Operational
Corporate Officer/Principal | 2 |
President | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
CJ CORPORATION | Consumer Non-Durables |
Private companies | 1 |
---|---|
Abxign, Inc.
![]() Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | Health Technology |
- Stock Market
- Insiders
- Young-Sun Sohn
- Experience